Sanuwave Health Current Ratio 2010-2025 | SNWV
Sanuwave Health current ratio from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| Sanuwave Health Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $0.02B | $0.05B | 0.40 |
| 2024-12-31 | $0.02B | $0.04B | 0.43 |
| 2024-09-30 | $0.01B | $0.08B | 0.12 |
| 2024-06-30 | $0.01B | $0.06B | 0.15 |
| 2024-03-31 | $0.01B | $0.07B | 0.15 |
| 2023-12-31 | $0.01B | $0.07B | 0.15 |
| 2023-09-30 | $0.01B | $0.09B | 0.09 |
| 2023-06-30 | $0.01B | $0.08B | 0.08 |
| 2023-03-31 | $0.01B | $0.07B | 0.06 |
| 2022-12-31 | $0.01B | $0.06B | 0.11 |
| 2022-09-30 | $0.01B | $0.05B | 0.13 |
| 2022-06-30 | $0.01B | $0.05B | 0.10 |
| 2022-03-31 | $0.00B | $0.05B | 0.06 |
| 2021-12-31 | $0.00B | $0.06B | 0.08 |
| 2021-09-30 | $0.01B | $0.05B | 0.10 |
| 2021-06-30 | $0.01B | $0.04B | 0.12 |
| 2021-03-31 | $0.01B | $0.04B | 0.15 |
| 2020-12-31 | $0.01B | $0.04B | 0.22 |
| 2020-09-30 | $0.01B | $0.03B | 0.32 |
| 2020-06-30 | $0.00B | $0.02B | 0.10 |
| 2020-03-31 | $0.00B | $0.01B | 0.17 |
| 2019-12-31 | $0.00B | $0.01B | 0.20 |
| 2019-09-30 | $0.00B | $0.02B | 0.07 |
| 2019-06-30 | $0.00B | $0.02B | 0.06 |
| 2019-03-31 | $0.00B | $0.02B | 0.05 |
| 2018-12-31 | $0.00B | $0.02B | 0.07 |
| 2018-09-30 | $0.00B | $0.01B | 0.05 |
| 2018-06-30 | $0.00B | $0.02B | 0.08 |
| 2018-03-31 | $0.00B | $0.02B | 0.06 |
| 2017-12-31 | $0.00B | $0.01B | 0.11 |
| 2017-09-30 | $0.00B | $0.00B | 0.11 |
| 2017-06-30 | $0.00B | $0.01B | 0.06 |
| 2017-03-31 | $0.00B | $0.00B | 0.30 |
| 2016-12-31 | $0.00B | $0.01B | 0.12 |
| 2016-09-30 | $0.00B | $0.00B | 0.74 |
| 2016-06-30 | $0.00B | $0.00B | 0.36 |
| 2016-03-31 | $0.00B | $0.01B | 0.16 |
| 2015-12-31 | $0.00B | $0.00B | 0.43 |
| 2015-09-30 | $0.00B | $0.00B | 0.86 |
| 2015-06-30 | $0.00B | $0.00B | 1.47 |
| 2015-03-31 | $0.00B | $0.01B | 0.48 |
| 2014-12-31 | $0.00B | $0.01B | 0.65 |
| 2014-09-30 | $0.01B | $0.01B | 0.82 |
| 2014-06-30 | $0.01B | $0.00B | 6.90 |
| 2014-03-31 | $0.01B | $0.00B | 5.21 |
| 2013-12-31 | $0.00B | $0.00B | 0.27 |
| 2013-09-30 | $0.00B | $0.00B | 0.30 |
| 2013-06-30 | $0.00B | $0.01B | 0.06 |
| 2013-03-31 | $0.00B | $0.01B | 0.14 |
| 2012-12-31 | $0.00B | $0.00B | 0.19 |
| 2012-09-30 | $0.00B | $0.00B | 0.39 |
| 2012-06-30 | $0.00B | $0.00B | 0.85 |
| 2012-03-31 | $0.00B | $0.00B | 1.33 |
| 2011-12-31 | $0.01B | $0.00B | 1.97 |
| 2011-09-30 | $0.01B | $0.00B | 2.58 |
| 2011-06-30 | $0.01B | $0.00B | 3.06 |
| 2011-03-31 | $0.00B | $0.01B | 0.39 |
| 2010-12-31 | $0.00B | $0.01B | 0.14 |
| 2010-09-30 | $0.00B | $0.01B | 0.11 |
| 2010-06-30 | $0.00B | $0.01B | 0.23 |
| 2010-03-31 | $0.00B | $0.00B | 0.48 |
| 2009-12-31 | $0.00B | $0.00B | 0.94 |
| 2009-09-30 | $0.00B | $0.00B | 1.59 |
| 2009-06-30 | $0.00B | $0.00B | 0.01 |
| 2009-03-31 | $0.00B | $0.00B | 0.05 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.306B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $219.828B | 25.79 |
| Boston Scientific (BSX) | United States | $156.585B | 37.40 |
| Stryker (SYK) | United States | $152.939B | 31.98 |
| EssilorLuxottica (ESLOY) | France | $137.925B | 0.00 |
| Medtronic (MDT) | Ireland | $117.956B | 16.72 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.343B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.576B | 24.87 |
| ResMed (RMD) | United States | $40.103B | 30.12 |
| GE HealthCare Technologies (GEHC) | United States | $35.596B | 16.90 |
| Agilent Technologies (A) | United States | $33.957B | 22.14 |
| Terumo (TRUMY) | Japan | $25.643B | 33.31 |
| Koninklijke Philips (PHG) | Netherlands | $24.709B | 17.34 |
| Insulet (PODD) | United States | $20.568B | 80.74 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.989B | 12.20 |
| Baxter (BAX) | United States | $14.636B | 10.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.656B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.891B | 23.98 |
| Lantheus Holdings (LNTH) | United States | $5.010B | 12.64 |
| Perrigo (PRGO) | Ireland | $3.867B | 9.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.770B | 16.84 |
| Haemonetics (HAE) | United States | $3.587B | 16.34 |
| Envista Holdings (NVST) | United States | $3.515B | 29.21 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.138B | 23.14 |
| LeMaitre Vascular (LMAT) | United States | $1.863B | 41.65 |
| QuidelOrtho (QDEL) | United States | $1.764B | 12.14 |
| AtriCure (ATRC) | United States | $1.645B | 0.00 |
| Acuren (TIC) | United States | $1.367B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.332B | 29.96 |
| AdaptHealth (AHCO) | United States | $1.294B | 13.14 |
| Neogen (NEOG) | United States | $1.176B | 15.06 |
| Phibro Animal Health (PAHC) | United States | $1.172B | 14.98 |
| BioLife Solutions (BLFS) | United States | $1.063B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.987B | 0.00 |
| InMode (INMD) | Israel | $0.919B | 9.26 |
| Kestra Medical Technologies (KMTS) | United States | $0.847B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.704B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| Valneva SE (VALN) | France | $0.648B | 0.00 |
| Owens & Minor (OMI) | United States | $0.608B | 5.04 |
| Evolus (EOLS) | United States | $0.598B | 0.00 |
| CeriBell (CBLL) | United States | $0.541B | 0.00 |
| Surmodics (SRDX) | United States | $0.524B | 0.00 |
| ZimVie (ZIMV) | United States | $0.524B | 23.82 |
| SNDL (SNDL) | Canada | $0.394B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.358B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.97 |
| Quanterix (QTRX) | United States | $0.324B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.310B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.269B | 79.67 |
| Cerus (CERS) | United States | $0.260B | 0.00 |
| Omeros (OMER) | United States | $0.256B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.251B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.246B | 20.77 |
| Biote (BTMD) | United States | $0.239B | 6.72 |
| Verano Holdings (VRNOF) | United States | $0.238B | 0.00 |
| Brainsway (BWAY) | Israel | $0.227B | 60.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.222B | 0.00 |
| Organigram Global (OGI) | Canada | $0.198B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.45 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.172B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Exagen (XGN) | United States | $0.157B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.83 |
| MacroGenics (MGNX) | United States | $0.105B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Jin Medical (ZJYL) | China | $0.104B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 12.77 |
| Quipt Home Medical (QIPT) | United States | $0.093B | 0.00 |
| Apyx Medical (APYX) | United States | $0.091B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.090B | 0.00 |
| Safety Shot (SHOT) | United States | $0.088B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Veru (VERU) | United States | $0.077B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Agape ATP (ATPC) | $0.067B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.059B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.38 |
| Nephros (NEPH) | United States | $0.038B | 51.43 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.010B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |